Literature DB >> 9502211

At low doses, harmaline increases forelimb tremor in the rat.

J A Stanford1, S C Fowler.   

Abstract

A behavioral preparation especially sensitive to low-dose drug effects on fine motor behavior in rats was used to assess the tremorogenic effects of harmaline, an indole alkaloid and beta-carboline derivative. Rats that were trained to press downward on a force transducer for water reinforcement were initially administered harmaline (0.5 and 1.0 mg/kg) in an acute dosing regime. Immediately following the day of initial acute exposure to 1 mg/kg, 3 consecutive days at this dose ensued, providing for a 4-day, repeated-dosing analysis. Harmaline did not significantly suppress task engagement during either acute or repeated dosing. Acute administration of harmaline dose-dependently increased power in the high-frequency (10-25 Hz) band of the power spectrum (tremor) without affecting overall forelimb force output. Upon continued administration, tremor remained significantly elevated above vehicle values. Harmaline also slowed the rats' licking frequency, an effect that did not diminish with repeated dosing. Harmaline increased the durations of individual responses during acute dosing and continued to exert this effect with repeated dosing. The effects reported in the present study may represent low-dose harmaline-induced alterations in the olivo-cerebellar system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502211     DOI: 10.1016/s0304-3940(97)00974-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Harmaline induces different motor effects on facial vs. skeletal-motor systems in alert cats.

Authors:  S Morcuende; J A Trigo; J M Delgado-García; A Gruart
Journal:  Neurotox Res       Date:  2001-11       Impact factor: 3.911

2.  Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.

Authors:  Hassan Abbassian; Benjamin J Whalley; Vahid Sheibani; Mohammad Shabani
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

3.  Considerations Using Harmaline for a Primate Model of Tremor.

Authors:  Edward M Bello; Madeline Blumenfeld; Joan Dao; Jordan D S Krieg; Lucius K Wilmerding; Matthew D Johnson
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-09-13

4.  Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor.

Authors:  Adrian Handforth
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-12

5.  An indole alkaloid from a tribal folklore inhibits immediate early event in HSV-2 infected cells with therapeutic efficacy in vaginally infected mice.

Authors:  Paromita Bag; Durbadal Ojha; Hemanta Mukherjee; Umesh Chandra Halder; Supriya Mondal; Nidhi S Chandra; Suman Nandi; Ashoke Sharon; Mamta Chawla Sarkar; Sekhar Chakrabarti; Debprasad Chattopadhyay
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.